Hourigan, C S
Gale, R P
Gormley, N J
Ossenkoppele, G J
Walter, R B
Article History
Received: 6 February 2017
Revised: 15 March 2017
Accepted: 21 March 2017
First Online: 7 April 2017
Competing interests
: CSH receives research funding from Merck Sharpe and Dohme and SELLAS Life Sciences Group AG. RPG is a part-time employee of Celgene Corp. The remaining authors declare no conflict of interest.